Human Immunodeficiency Virus (Hiv) Drugs Market Comprehensive Analysis Highlights Emerging Regions and Sectoral Shifts
Market Overview According to the research report published by Polaris Market Research, the global Human Immunodeficiency Virus (HIV) drugs market was valued at USD 30.51 billion in 2021 and is expected to reach USD 47.48 billion by 2030, to grow at a CAGR of 5.2% during the forecast period. The HIV drugs market encompasses a wide range of therapeutic agents designed to inhibit viral replication and bolster immune function. The market includes nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), integrase strand transfer inhibitors (INSTIs), and entry inhibitors, among others. Combination therapies have become the standard of care, offering patients more comprehensive and simplified treatment regimens. With increasing government support, growing healthcare expenditure, and the expansion of treatment programs in both developed and developing regions, the demand for HIV medications is ex...